US 11135280
Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity
granted A61KA61K39/12
Quick answer
US patent 11135280 (Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity) held by INTEGRATED BIOTHERAPEUTICS, INC. expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INTEGRATED BIOTHERAPEUTICS, INC.
- Grant date
- Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K39/12